Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Pharmaids Pharmaceuticals Ltd (NSE: PHARMAID), ISIN INE117D01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
PHARMAID last traded at ₹30.11 (+1.59%), with a 52-week range of ₹25.60 to ₹66.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 32.99%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 38/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.